NVAX News Alert Novavax Inc (NVAX) 8.80 02/14/2015 08:53:12

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Novavax Inc (NVAX) 8.80 $NVAX

Jim Cramer's Top Stock Picks: ACT PCLN CLX HAIN WWAV NVAX
at The Street - Sat Feb 14, 5:00AM CST
Cramer says buy Priceline after it reports earnings but before the conference call, and Clorox is the winner in the consumer packaged-goods sector.
WWAV: 38.65 (+0.61), HAIN: 59.48 (+0.45), ACT: 285.37 (+3.71), CLX: 109.00 (+0.74), NVAX: 8.80 (+0.40), PCLN: 1,103.37 (+11.42)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Feb 13, 7:03PM CST
Cramer will be doing a lot of listening to what companies have to say about their business.
ACT: 285.37 (+3.71), BDX: 143.71 (+0.72), SE: 36.81 (+0.61), RRGB: 77.77 (-0.20), CLX: 109.00 (+0.74), WMT: 85.81 (-0.08), STZ: 113.03 (-0.48), SAM: 303.26 (-0.97), PLKI: 61.07 (+0.44), WM: 51.29 (-1.41), PCLN: 1,103.37 (+11.42), FOSL: 98.44 (-0.30), GT: 25.91 (-0.30), COG: 28.10 (+0.18), NVAX: 8.80 (+0.40), DE: 90.04 (+0.67), EOG: 96.92 (+2.12), JWN: 79.41 (+0.04), PG: 85.90 (-0.13), CL: 70.08 (+0.23)

Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)

Novavax starts early stage Ebola vaccine trial
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 12:18PM CST

JNJ: 99.62 (+1.18), NVAX: 8.80 (+0.40), MRK: 58.81 (-0.07), NLNK: 38.84 (+1.51), GSK: 47.94 (+1.99)

Novavax Announces Initiation of Ebola Vaccine Phase 1 Clinical Trial Supported by Non-Human Primate Challenge Data and Documented Rapid Manufacturing Capabilities
Thomson Reuters ONE - Thu Feb 12, 7:31AM CST
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
NVAX: 8.80 (+0.40)

Novavax Has Returned 81.7% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Wed Feb 11, 4:42PM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 9 months, Novavax has returned 81.70% as of today's recent price of $8.24.
NVAX: 8.80 (+0.40)

Uptrend Call Working As Novavax Stock Rises 67.4% (NVAX)
Comtex SmarTrend(R) - Wed Feb 04, 10:57AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 9 months, Novavax has returned 67.36% as of today's recent price of $7.59.
NVAX: 8.80 (+0.40)

Insider Trading Alert - TIPT, VNTV And NVAX Traded By Insiders
at The Street - Wed Feb 04, 10:15AM CST
Stocks with insider trader activity include TIPT, VNTV and NVAX
NVAX: 8.80 (+0.40), TIPT: 7.49 (+0.01), VNTV: 38.33 (+0.82)

Novavax Up 75.0% Since SmarTrend Uptrend Call (NVAX)
Comtex SmarTrend(R) - Wed Jan 28, 9:32AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 8 months, Novavax has returned 74.97% as of today's recent price of $7.94.
NVAX: 8.80 (+0.40)

63.0% Return Seen to Date on SmarTrend Novavax Call (NVAX)
Comtex SmarTrend(R) - Wed Jan 21, 9:06AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 8 months, Novavax has returned 62.95% as of today's recent price of $7.39.
NVAX: 8.80 (+0.40)

Trade-Ideas: Novavax (NVAX) Is Today's Strong On High Relative Volume Stock
at The Street - Wed Jan 21, 9:02AM CST
Trade-Ideas LLC identified Novavax (NVAX) as a strong on high relative volume candidate
NVAX: 8.80 (+0.40)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 4:38PM CST

MACK: 10.22 (+0.40), NFLX: 466.10 (+9.37), WWD: 48.59 (+0.11), ACTG: 13.13 (+0.04), NVAX: 8.80 (+0.40), CONN: 24.69 (-0.07), ILMN: 198.54 (+1.81), ARNA: 4.55 (+0.02), CREE: 37.51 (+0.08)

Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics
PR Newswire - Tue Jan 20, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Novavax Inc. (NASDAQ: NVAX), Isis Pharmaceuticals Inc. (NASDAQ: ISIS), OPKO Health Inc. (NYSE: OPK), Nanosphere Inc. (NASDAQ: NSPH), and NewLink Genetics Corporation (NASDAQ: NLNK). Free research reports can be accessed at the links given below. On Friday, January 16, 2015, the NASDAQ Composite ended at 4,634.38, up 1.39%, the Dow Jones Industrial Average advanced 1.10%, to finish the day at 17,511.57, and the S&P 500 closed at 2,019.42, up 1.34%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 814.62, up 1.92%, with the index also advancing 15.08% in the previous three months. Register for your complimentary reports at the links given below.
ISIS: 63.86 (-0.43), OPK: 13.80 (-0.28), NVAX: 8.80 (+0.40), NLNK: 38.84 (+1.51), NSPH: 0.25 (unch)

Most active Nasdaq-traded stocks
AP - Fri Jan 16, 5:20PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 31.85 (-0.09), AMD: 3.15 (+0.03), NVAX: 8.80 (+0.40), FB: 75.74 (-0.49), MSFT: 43.87 (+0.78), INTC: 34.36 (+0.23), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)

Watch for Novavax to Potentially Pullback After Gaining 9.84% Yesterday
Comtex SmarTrend(R) - Fri Jan 16, 4:04PM CST
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $6.06 to a high of $6.92. Yesterday, the shares gained 9.8%, which took the trading range above the 3-day high of $6.57 on volume of 40.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 8.80 (+0.40)

Nasdaq stocks posting largest percentage increases
AP - Fri Jan 16, 12:19PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
PSIX: 51.65 (+1.82), EOPN: 8.55 (-0.01), ASPS: 22.32 (+0.09), NVAX: 8.80 (+0.40), DEPO: 18.38 (+0.20), NYNY: 6.33 (+0.06), CRRC: 22.96 (+0.22)

Novavax (NVAX) Jumps: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 8:11AM CST
Novavax, Inc. (NVAX) was a big mover last session, as the company saw its shares rise over 6% on the day.
NVAX: 8.80 (+0.40), AMAG: 41.49 (+0.23)

Jim Cramer's Top Stock Picks: NVAX TGT BMRN RCPT
at The Street - Fri Jan 16, 5:00AM CST
Cramer says Novavax should be on every investor's watch list while Target should have a better 2015 than 2014.
BMRN: 100.76 (+1.98), NVAX: 8.80 (+0.40), TGT: 76.12 (-0.75), RCPT: 115.83 (-0.66)

Cramer's Mad Money: Go Patriotic (1/15/15)
SA Editor Michael Hopkins - at Seeking Alpha - Thu Jan 15, 11:29PM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, January 15. The Swiss National Bank surprised investors globally when it cut its currency cap with the euro, sending markets - including those in the...
GPRO: 45.27 (-0.02), FEYE: 42.26 (+2.63), BMRN: 100.76 (+1.98), S: 5.23 (+0.08), NVAX: 8.80 (+0.40), TGT: 76.12 (-0.75), RCPT: 115.83 (-0.66), TWTR: 48.50 (+0.55), MSFT: 43.87 (+0.78), ARRY: 8.05 (+0.08)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Justin Gaethje Triumphs at UFC 313: A Night to Remember

Updated Category News Views 479

Justin Gaethje's Unforgettable Victory at UFC 313 In a thrilling matchup at UFC 313, held in a vibrant arena packed with fans, Justin Gaethje showcased his exceptional fighting prowess against Rafael Fiziev. The event captured the hearts and cheers of 18,869 spectators, all eager to witness the action unfold in the octagon. A Memorable Co-Main Event The co-main event...

Continue Reading
Badger Infrastructure Solutions Announces Impressive Financial Results

Updated Category News Views 219

Strong Performance by Badger Infrastructure Solutions Ltd. Badger Infrastructure Solutions Ltd. (TSX: BDGI) has published results for the fourth quarter and the full year 2024, demonstrating impressive growth in revenue, adjusted EBITDA, and net earnings. All figures are reported in U.S. dollars for consistency. The highlights from this report encapsulate the company's...

Continue Reading
Investors Urged to Act: Class Action Against Hims & Hers Health

Updated Category News Views 191

Investors Take Notice of Class Action for Hims & Hers Health In an important development for shareholders, a reminder has been issued regarding the impending lead plaintiff deadline in a class action lawsuit against Hims & Hers Health, Inc. Many investors with losses exceeding $100,000 are urged to consider their legal options as the deadline approaches quickly. Key...

Continue Reading
HWH International and SHRG Embrace Robotics for Growth

Updated Category News Views 94

HWH International and SHRG Set Sights on Robotics Innovation HWH International Inc. (NASDAQ: HWH) and its partner, Sharing Services Global Corporation (OTC: SHRG), are embarking on an exciting journey in the robotics field. Their latest collaboration highlights the significance of robotics and automation in various sectors. With SHRG's membership in the Association for...

Continue Reading
Redfin's Latest Trends: Home Prices Increase as Market Stabilizes

Updated Category News Views 231

US Home Prices Show Modest Growth in December Recently, it was reported that U.S. home prices rose by 0.4% in December on a seasonally adjusted basis, which indicates a positive trend in the market. This growth is slightly more than the 0.5% observed in November, signaling a gradual recovery as we move further into the housing market season. Yearly Performance of Home...

Continue Reading